Future research should consider the functional role of FOXO1 in chemoresistance and the concrete mechanism of ADAMTS9-AS2 (such as the phosphoinositide 3-kinase/Akt pathway) in the pathogenesis of ccRCC. The gene discussed is FOXO1; the disease is nonpapillary renal cell carcinoma.